Cuffed Versus Uncuffed Tracheal Tubes in Neonates Undergoing Elective Surgery
Launched by KASR EL AINI HOSPITAL · Mar 17, 2022
Trial Information
Current as of May 30, 2025
Completed
Keywords
ClinConnect Summary
Neonates will be recruited into the trial during pre-operative assessment. Recruited neonates will be randomly assigned to one of two groups in a 1:1 ratio; (group C) to receive a cuffed ETT and (group U) to receive an uncuffed ETT for airway management. Randomization will be achieved using a computer-generated sequence. Concealment will be achieved using opaque envelopes.
All neonates will be anesthetized in accordance with the local policy of pediatric anesthesia unit in Abu El-Reesh pediatric hospital-Cairo university after ethics committee approval.
After preoperative examination and ...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • • Neonates (infant in the first 28 days after birth)
- • Full term (more than 37 gestational weeks)
- • More than 3 kg bodyweight
- • ASA I-II
- • Scheduled for elective surgeries under general anesthesia requiring endotracheal intubation.
- Exclusion Criteria:
- • • Parents or legally authorized personnel refusal.
- • Anatomical abnormalities of upper air way.
- • Emergency surgery.
- • Low birth weight less than 3 kg
- • Surgery longer than 2 hours
- • Premature neonates
- • Upper airway surgery
- • Requirement for postoperative ventilation
About Kasr El Aini Hospital
Kasr El Aini Hospital, a prestigious medical institution affiliated with Cairo University, is dedicated to advancing healthcare through innovative clinical research. With a commitment to excellence, the hospital serves as a leading sponsor of clinical trials, leveraging its state-of-the-art facilities and a multidisciplinary team of healthcare professionals. The institution focuses on a diverse range of therapeutic areas, aiming to improve patient outcomes and contribute to the global medical community. By fostering collaboration and adhering to the highest ethical standards, Kasr El Aini Hospital plays a pivotal role in the development of new treatments and therapies.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Cairo, , Egypt
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials